---
title: "Cohbar (CWBR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CWBR.US.md"
symbol: "CWBR.US"
name: "Cohbar"
industry: "Biotechnology"
---

# Cohbar (CWBR.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; an...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CWBR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CWBR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CWBR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.